Testing effectiveness (Phase 2)Study completedNCT02363738
What this trial is testing
12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression
Who this might be right for
Bipolar Depression
University Health Network, Toronto 60